183 related articles for article (PubMed ID: 38339238)
1. Small Cajal Body-Specific RNA12 Promotes Carcinogenesis through Modulating Extracellular Matrix Signaling in Bladder Cancer.
Lu Q; Wang J; Tao Y; Zhong J; Zhang Z; Feng C; Wang X; Li T; He R; Wang Q; Xie Y
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339238
[No Abstract] [Full Text] [Related]
2. Oncogene SCARNA12 as a potential diagnostic biomarker for colorectal cancer.
Zhang H; Liu X; Zhang W; Deng J; Lin C; Qi Z; Li Y; Gu Y; Wang Q; Shen L; Wang Z
Mol Biomed; 2023 Nov; 4(1):37. PubMed ID: 37907779
[TBL] [Abstract][Full Text] [Related]
3. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
4. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
5. α-E-Catenin (CTNNA1) Inhibits Cell Proliferation, Invasion and EMT of Bladder Cancer.
Chi Q; Xu H; Song D; Wang Z; Wang Z; Ma G
Cancer Manag Res; 2020; 12():12747-12758. PubMed ID: 33364826
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG3 enhances BMI1 mRNA stability by binding and regulating c-MYC: Implications for the carcinogenic role of SNHG3 in bladder cancer.
Xie J; Ni J; Shi H; Wang K; Ma X; Li W; Peng B
Cancer Med; 2023 Mar; 12(5):5718-5735. PubMed ID: 36208024
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB.
Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S
Front Immunol; 2023; 14():1253586. PubMed ID: 37790935
[TBL] [Abstract][Full Text] [Related]
8. LINC01451 drives epithelial-mesenchymal transition and progression in bladder cancer cells via LIN28/TGF-β/Smad pathway.
Shi H; Xie J; Wang K; Li W; Yin L; Wang G; Wu Z; Ni J; Mao W; Guo C; Peng B
Cell Signal; 2021 May; 81():109932. PubMed ID: 33516780
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
[TBL] [Abstract][Full Text] [Related]
10. Investigating the impact of regulatory B cells and regulatory B cell-related genes on bladder cancer progression and immunotherapeutic sensitivity.
Zhou J; Zhou R; Zhu Y; Deng S; Muhuitijiang B; Li C; Shi X; Zhang L; Tan W
J Exp Clin Cancer Res; 2024 Apr; 43(1):101. PubMed ID: 38566204
[TBL] [Abstract][Full Text] [Related]
11. LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer.
He YC; Bi YG; Jiang L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8740-8746. PubMed ID: 32964962
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA hsa_circ_0017247 acts as an oncogene in bladder cancer by inducing Wnt/β-catenin signaling pathway.
Han CT; Bao QY; Cheng SJ; Liu M; Qian HN; Li D
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1081-1087. PubMed ID: 32096177
[TBL] [Abstract][Full Text] [Related]
13. Nucleolar and Spindle Associated Protein 1 (NUSAP1) Promotes Bladder Cancer Progression Through the TGF-β Signaling Pathway.
Gao S; Yin H; Tong H; Zhan K; Yang G; Hossain MA; Li T; Gou X; He W
Onco Targets Ther; 2020; 13():813-825. PubMed ID: 32099387
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/ miR-1-3p axis in bladder cancer.
Tan Z; Jiang Y; Liang L; Wu J; Cao L; Zhou X; Song Z; Ye Z; Zhao Z; Feng H; Dong Z; Lin S; Zhou Z; Wang Y; Li X; Guan F
J Exp Clin Cancer Res; 2022 Jul; 41(1):228. PubMed ID: 35864552
[TBL] [Abstract][Full Text] [Related]
15. NUPR1 imparts oncogenic potential in bladder cancer.
Zhang L; Gao S; Shi X; Chen Y; Wei S; Mi Y; Zuo L; Qi C
Cancer Med; 2023 Mar; 12(6):7149-7163. PubMed ID: 36468653
[TBL] [Abstract][Full Text] [Related]
16. NFE2L3 promotes tumor progression and predicts a poor prognosis of bladder cancer.
Qian J; Huang C; Zhu Z; He Y; Wang Y; Feng N; He S; Li X; Zhou L; Zhang C; Gong Y
Carcinogenesis; 2022 Jun; 43(5):457-468. PubMed ID: 35022660
[TBL] [Abstract][Full Text] [Related]
17.
Wang SS; Zhai GQ; Chen G; Huang ZG; Zhang Y; Zhang LJ; Dang YW; Li SH; Yan HB
Cancer Biother Radiopharm; 2023 Nov; 38(9):650-662. PubMed ID: 35704039
[No Abstract] [Full Text] [Related]
18. NEDD4L inhibits migration, invasion, cisplatin resistance and promotes apoptosis of bladder cancer cells by inactivating the p62/Keap1/Nrf2 pathway.
Wu Q; Zhang H; You S; Xu Z; Liu X; Chen X; Zhang W; Ye J; Li P; Zhou X
Environ Toxicol; 2023 Jul; 38(7):1678-1689. PubMed ID: 37087754
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
[TBL] [Abstract][Full Text] [Related]
20. SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy.
Yin J; Cai G; Wang H; Chen W; Liu S; Huang G
Cell Div; 2023 Jun; 18(1):9. PubMed ID: 37301821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
